HIV News and Research

RSS

Immune response that protects against infections also drives HIV latency

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, lurking in cells only to erupt anew, researchers at Duke Health report.

15 Nov 2023

Cannabis shows promise in easing endometriosis pain, new research suggests

The Journal of Clinical Medicine review explores cannabis as a self-management strategy for endometriosis pain, revealing its potential to reduce gut inflammation and improve gut permeability, thereby alleviating bloating and suppressing pain through interactions with the endocannabinoid system and gut microbiota.

14 Nov 2023

COVID-19 pandemic slowed progress toward ending HIV epidemic in the U.S.

The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities, according to UC Francisco researchers leading the largest U.S. evaluation of the impact of the public health crisis on people with HIV.

14 Nov 2023

Study reveals mechanisms underlying non-suppressible HIV viremia

Human immunodeficiency virus (HIV) works by entering specific immune cells and replicating inside them.

14 Nov 2023

Study provides insights into longevity of neutralizing antibodies in HIV-1 infection

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people.

14 Nov 2023

Understanding factors influencing PrEP prescribing for adolescents

HIV pre-exposure prophylaxis (PrEP), a daily dose of two medications meant to prevent HIV infection in high-risk people, has changed public health dramatically in recent years.

14 Nov 2023

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

Republicans in Congress are "trying to wipe out federal funding to end the HIV epidemic."

14 Nov 2023

Young people begin to use nicotine through vaping rather than through cigarettes

Young adults are now more likely to vape than to use traditional cigarettes. After years of public health success in decreasing the numbers of people using cigarettes, researchers are seeing striking increases in the numbers of young people who use e-cigarettes regularly – so much so that, for the first time, there are more young people who begin to use nicotine through vaping rather than through cigarettes.

13 Nov 2023

KAIST researchers develop an IV needle that irreversibly softens upon insertion

Intravenous (IV) injection is a method commonly used in patient's treatment worldwide as it induces rapid effects and allows treatment through continuous administration of medication by directly injecting drugs into the blood vessel.

13 Nov 2023

Study narrows down potential causes of Long COVID brain fog and other neuropsychiatric symptoms

Neuropsychiatric symptoms of Long COVID, including brain fog, inability to concentrate, and headache, have puzzled researchers and clinicians, who are hunting for those symptoms' causes.

10 Nov 2023

Rise in US congenital syphilis cases linked to testing and treatment failures, CDC reports

An analysis in the Morbidity and Mortality Weekly Report highlights the surge in congenital syphilis cases in the US due to gaps in testing and treatment, underscoring the need for enhanced prenatal care strategies to combat this preventable disease effectively.

8 Nov 2023

US to cover HIV prevention drugs for older Americans to stem spread of the virus

A proposed federal policy aims to protect older Americans from contracting HIV by offering free preventive medication, the latest effort to catch up to much of Europe and Africa in stemming the spread of the virus.

8 Nov 2023

Omicron variant BA.2.86 spreads faster, but current antivirals hold the line

Researchers discover the BA.2.86 Omicron lineage with higher transmission potential than current dominant strains, yet show that existing antivirals remain effective. Despite its higher infectivity, BA.2.86 exhibits lower pathogenicity in hamsters, indicating decreased replication capacity may lead to less severe infections.

7 Nov 2023

Study launched to test a vaginal film that slowly dissolves over the course of 30 days

A vaginal film designed to slowly dissolve over the course of 30 days is being put to the test for the first time in a study launched this week that aims to determine its feasibility and acceptability as a potential HIV prevention method for women.

2 Nov 2023

NIH awards $2.1 million to UCLA to end the HIV epidemic

The National Institutes of Health (NIH) has granted $2.1 million to UCLA's Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.

2 Nov 2023

Study finds health care barriers for most pet owners with HIV

People living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of Florida College of Public Health and Health Professions researcher finds.

1 Nov 2023

Next-generation vaccine candidates protect against multiple strains of influenza and last longer

Recent preclinical results indicate novel next-generation vaccine candidates developed at Cleveland Clinic protect against multiple strains of influenza and last longer than vaccines currently in use.

31 Oct 2023

AI may help identify potential gonorrhea vaccine proteins

Gonorrhea, a sexually transmitted bacterial infection that affects more than 80 million people worldwide every year, has become resistant to almost all known antibiotics.

31 Oct 2023

Brain autopsy study of intimate partner violence victims shows extensive brain damage

The largest brain autopsy study of women who had experienced intimate partner violence reveals substantial vascular and white matter damage in the brain, but no evidence of chronic traumatic encephalopathy (CTE), the neurodegenerative disease recognized among male contact sports athletes who sustain repeated head trauma.

30 Oct 2023

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Researchers found that SARS-CoV-2 antigens can persist in the body for up to 14 months after initial infection, challenging the idea that COVID-19 is a transient illness. This finding has implications for understanding long-term effects of the virus and could influence future treatments and vaccines.

30 Oct 2023

HIV News and Research

Immune response that protects against infections also drives HIV latency

Cannabis shows promise in easing endometriosis pain, new research suggests

COVID-19 pandemic slowed progress toward ending HIV epidemic in the U.S.

Study reveals mechanisms underlying non-suppressible HIV viremia

Study provides insights into longevity of neutralizing antibodies in HIV-1 infection

Understanding factors influencing PrEP prescribing for adolescents

Do Republican spending cuts threaten federal HIV funding? For some programs, yes.

Young people begin to use nicotine through vaping rather than through cigarettes

KAIST researchers develop an IV needle that irreversibly softens upon insertion

Study narrows down potential causes of Long COVID brain fog and other neuropsychiatric symptoms

Rise in US congenital syphilis cases linked to testing and treatment failures, CDC reports

US to cover HIV prevention drugs for older Americans to stem spread of the virus

Omicron variant BA.2.86 spreads faster, but current antivirals hold the line

Study launched to test a vaginal film that slowly dissolves over the course of 30 days

NIH awards $2.1 million to UCLA to end the HIV epidemic

Study finds health care barriers for most pet owners with HIV

Next-generation vaccine candidates protect against multiple strains of influenza and last longer

AI may help identify potential gonorrhea vaccine proteins

Brain autopsy study of intimate partner violence victims shows extensive brain damage

SARS-CoV-2 antigens stick around: Study finds virus markers can linger for over a year

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News